GSK to open Boston office to keep an eye on local biotechs (and will stop paying docs to promote) http://www.bostonglobe.com/business/2014/09/18/glaxosmithkline-opening-cambridge-office-will-stop-paying-doctors-promote-its-medicines/vgjukJGamzRyc6M0XAQuUJ/story.html?p1=Article_InThisSection_Bottom And just for balance, GSK will pay pay $500 million to China because of bribery activities (I'm sure that would not go on in the US) -- http://www.nytimes.com/2014/09/20/business/international/china-fines-glaxo-glaxosmithkline-nearly-500-million-in-bribery-case.html?hp&action=click&pgtype=Homepage&version=HpSum&module=second-column-region®ion=top-news&WT.nav=top-news&_r=0